Department of General Practice and Rural Medicine, James Cook University, Mackay, Queensland, Australia.
College of Medicine and Dentistry, James Cook University, Mackay, Queensland, Australia.
Br J Surg. 2017 Aug;104(9):1123-1130. doi: 10.1002/bjs.10588. Epub 2017 Jun 28.
Surgical-site infections (SSIs) increase patient morbidity and costs. The aim was to identify and synthesize all RCTs evaluating the effect of topical antibiotics on SSI in wounds healing by primary intention.
The search included Ovid MEDLINE, Ovid Embase, the Cochrane Wounds Specialized Register, Central Register of Controlled Trials and EBSCO CINAHL from inception to May 2016. There was no restriction of language, date or setting. Two authors independently selected studies, extracted data and assessed risk of bias. When sufficient numbers of comparable trials were available, data were pooled in meta-analysis.
Fourteen RCTs with 6466 participants met the inclusion criteria. Pooling of eight trials (5427 participants) showed that topical antibiotics probably reduced the risk of SSI compared with no topical antibiotic (risk ratio (RR) 0·61, 95 per cent c.i. 0·42 to 0·87; moderate-quality evidence), equating to 20 fewer SSIs per 1000 patients treated. Pooling of three trials (3012 participants) for risk of allergic contact dermatitis found no clear difference between antibiotics and no antibiotic (RR 3·94, 0·46 to 34·00; very low-quality evidence). Pooling of five trials (1299 participants) indicated that topical antibiotics probably reduce the risk of SSI compared with topical antiseptics (RR 0·49, 0·30 to 0·80; moderate-quality evidence); 43 fewer SSIs per 1000 patients treated. Pooling of two trials (541 participants) showed no clear difference in the risk of allergic contact dermatitis with antibiotics or antiseptic agents (RR 0·97, 0·52 to 1·82; very low-quality evidence).
Topical antibiotics probably prevent SSI compared with no topical antibiotic or antiseptic. No conclusion can be drawn regarding whether they cause allergic contact dermatitis.
手术部位感染(SSI)会增加患者的发病率和医疗成本。本研究旨在确定并综合评估所有随机对照试验(RCT),以评估局部应用抗生素对一期愈合伤口 SSI 的影响。
检索了 Ovid MEDLINE、Ovid Embase、Cochrane 伤口专业注册库、CENTRAL 和 EBSCO CINAHL 数据库,检索时间从建库至 2016 年 5 月。未对语言、日期或研究场所进行限制。两位作者独立筛选研究、提取数据并评估偏倚风险。当有足够数量的可比试验时,采用荟萃分析对数据进行合并。
纳入了 14 项 RCT(共 6466 名参与者)。对 8 项 RCT(5427 名参与者)的汇总分析显示,与不使用局部抗生素相比,局部应用抗生素可能降低 SSI 的风险(风险比 RR 0.61,95%置信区间 CI 0.42 至 0.87;中等质量证据),相当于每 1000 例患者中减少 20 例 SSI。对 3 项 RCT(3012 名参与者)汇总分析显示,抗生素与无抗生素相比,发生过敏接触性皮炎的风险无明显差异(RR 3.94,0.46 至 34.00;极低质量证据)。对 5 项 RCT(1299 名参与者)的汇总分析显示,与局部使用消毒剂相比,局部应用抗生素可能降低 SSI 的风险(RR 0.49,0.30 至 0.80;中等质量证据),每 1000 例患者中减少 43 例 SSI。对 2 项 RCT(541 名参与者)的汇总分析显示,抗生素与消毒剂相比,发生过敏接触性皮炎的风险无明显差异(RR 0.97,0.52 至 1.82;极低质量证据)。
与不使用局部抗生素或消毒剂相比,局部应用抗生素可能预防 SSI,但不能得出其是否会引起过敏接触性皮炎的结论。